China’s Regulator Has New Head But Will He Advance Further Reforms?

IP Protection On Agenda?

12 Sep 2023

A new commissioner has taken the reins at China's National Medical Products Administration, but the senior CCP official has so far given few clear indications about the changes he might bring.

Promotion career advancement stairs wooden man — New Commissioner Li Li takes reins at China's NMPA • Source: Shutterstock

After much speculation, Li Li was officially appointed commissioner of China's top drug regulatory agency, the National Medical Products Administration (NMPA), on 6 September.

Li, a secretary-general within the Chinese Communist Party (CCP), will ultimately oversee review, approval and postmarketing surveillance activities for all...